Envista Holdings Corporation

NVST · NYSE · ·

비교

US$24.66-2.5%11월 12일 종가

2026년 10월 2일까지의 수치 (2026년 11월 4일 제출 10-Q 기준)

1W: -2.0%
1M: +8.1%
3M

Envista Holdings Corporation (NVST) 주식 — 좋은 사업일까? — InspectStocks

Envista Holdings Corporation

NVST · NYSE · ·

비교

US$24.66-2.5%11월 12일 종가

2026년 10월 2일까지의 수치 (2026년 11월 4일 제출 10-Q 기준)

1W: -2.0%
1M: +8.1%
3M

Just reported

Q3 2026 results

From Envista's results release of 2026년 11월 4일; its quarterly report has since been filed.

Revenue
Actual
US$691.5M
+3.2% y/y
-5.3% q/q
Guided
—
No guide given
EPS, GAAP
Actual
US$3.11
Guided
—
No guide given
EPS, adjusted: US$0.40
Operating income, GAAP
Actual
US$515.2M
Guided
—
No guide given

Company outlook

Full year 2026

EPS, adjustedUS$1.54 – US$1.58Raised +2.3%

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

Keep exploring

The themes Envista is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

Highest-graded in Medical Instruments and Supplies

Graded A or B and worth $2B or more: A first, then the largest.

All 49 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

어떻게 돈을 버는가

Specialty Products & Technologies65%
Equipment & Consumables35%

매출 비중은 six months ended July 3, 2026 기준 추정치이며, 제출된 보고서의 수치가 아닙니다.

경쟁 상대

무엇을 파는가6

Dental implant systems and related products
Systems for replacing missing teeth, including implants, guided-surgery products, bone-regeneration materials, and tooth restorations. Brands include Nobel Biocare, Alpha-Bio Tec, and Implant Direct.
DTX Studio software
Software that helps dental professionals review patient images and plan implant procedures and restorations.
Orthodontic brackets, wires, and related products
Products orthodontists use to move teeth, including brackets, wires, tubes, bands, retainers, and laboratory products. Brands include Ormco and Damon.

3개 더 보기

Spark clear aligners
Removable clear trays used to straighten teeth, with software for planning and reviewing treatment.
Dental imaging equipment
Dental X-ray systems, digital sensors, and intraoral scanners used to capture images of patients’ teeth and mouths. Brands include DEXIS and i-CAT.
Dental consumables and infection-prevention products
Materials and tools used in routine dental care, including restorative materials, root-canal products, burs, bonding agents, cements, and surface disinfectants. Brands include Kerr, Sybron Endo, and Metrex.

누가 사는가6

General dentists buy imaging equipment, restorative materials, instruments, and other supplies for their practices, directly or through distributors.
Oral surgeons, periodontists, and other dental specialists buy implant systems, surgical products, and related planning tools.
Orthodontists buy brackets, wires, clear aligners, and treatment-planning tools.

3개 더 보기

Dental service organizations (DSOs), which operate groups of dental practices, buy products across several categories for use across their practices.
Dental laboratories buy products used to make dental restorations and other lab work.
Third-party distributors buy Envista products for resale to dental practices; they distributed 42% of the company’s products (2025, high). Henry Schein accounted for 12% of Envista sales (2025, high).

무엇에 기대고 있고, 무엇이 무너뜨릴 수 있는가

사업이 기대고 있는 것

1Some specially specified or qualified materials, components, or services come from a single supplier or a limited number of suppliers, so interruptions could delay production.
2Envista relies on distributors and other channel partners to reach customers; channel partners accounted for 89% of Equipment & Consumables segment sales (2025, high).
3Its products are subject to medical-device and other healthcare rules in the United States and other countries, including requirements for product clearances, manufacturing quality, and post-sale reporting.
4Demand for some dental procedures depends on patients’ ability or willingness to pay, since many dental costs are paid out of pocket.

잘못될 수 있는 일

1Trade duties can raise the cost of imported products and components. Envista reported tariff costs and uncertainty about the timing and recovery of some tariff refunds in its latest quarterly report.
2China’s volume-based procurement policies have cut prices for dental and medical consumables, which can reduce revenue from products sold into that market.
3Envista depends on distributors for a substantial portion of sales, and Henry Schein alone accounted for 12% of sales (2025, high); a change in that relationship or in its purchasing could affect sales.

전체 재무제표 보기 →

Envista Holdings Corporation 소개

Envista makes products used to diagnose, treat, and prevent problems with teeth and gums, and to improve smiles. It sells to general dentists, dental specialists, orthodontists, dental laboratories, and dental groups, directly and through distributors. Its products range from dental imaging and treatment-planning software to tooth-replacement systems, braces, restorative materials, root-canal products, and disinfectants.

본사: Brea, California
설립: 2018
임직원 수: approximately 12,000 (December 31, 2025, high)
상장 시장: NYSE
회계연도 종료: December 31

Envista Holdings Corporation이(가) 미국 증권거래위원회(SEC)에 직접 제출한 공시로 만들었습니다. 수치는 보고된 그대로이며, 주당 이력은 오늘의 주식 수 기준으로 재계산했습니다. 이것은 사업을 설명하는 자료입니다. 투자 자문이 아니며 어떤 매수나 매도도 권유하지 않습니다.

Just reported